CENTENNIAL, Colo.–(BUSINESS WIRE)–Arrow Electronics collaborates with Romanian startup .lumen on AI glasses that replicate the key functions of a guide dog on a wearable headset.
Author: Business Wire
National Vision Reaffirms Fiscal 2025 Outlook Ahead of Participation at the ICR Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reaffirmed its fiscal 2025 outlook ahead of its participation at the 2026 ICR Conference. The Company reaffirms its fiscal 2025 outloo…
Astoriom Appoints Will Edwards as Chief Executive Officer
ROCHDALE, United Kingdom–(BUSINESS WIRE)– #Astoriom–Astoriom today announced the appointment of Will Edwards, MBA as CEO to support global scale-up of sample management operations.
Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
Diorasis Therapeutics Appoints Richard A. Kresch, MD, to Board of Directors
BOSTON–(BUSINESS WIRE)– #genetherapy–Diorasis Therapeutics, a Boston-based biotechnology company developing durable gene therapies for glaucoma and other ophthalmic diseases, today announced the appointment of Richard A. Kresch, MD, to its Board of …
Abbelight kondigt een succesvolle Serie B-investering aan, geleid door AVANT BIO, om innovatie in beeldvorming te versnellen en toepassing in een ruimer klantenbestand op schaal te brengen
PARIJS–(BUSINESS WIRE)–Abbelight, een wereldleider en pionier in end-to-end oplossingen voor super-resolutiemicroscopie, kondigde vandaag een succesvolle Serie B-financieringsronde aan, geleid door AVANT BIO, een verstrekker van groeikapitaal die zic…
Abbelight kündigt erfolgreiche Serie-B-Finanzierungsrunde unter Federführung von AVANT BIO an, um Innovationen im Bereich Bildgebung voranzutreiben und deren Verbreitung bei einem größeren Kundenstamm zu fördern
PARIS–(BUSINESS WIRE)–Abbelight, ein Weltmarktführer und Pionier im Bereich End-to-End-Lösungen für die Superauflösungsmikroskopie, gab heute den erfolgreichen Abschluss einer Serie-B-Finanzierungsrunde unter der Leitung von AVANT BIO bekannt, einer …
Abbelight annuncia il successo dell'investimento di serie B guidato da AVANT BIO per accelerare l'innovazione dell'imaging e incrementare l'adozione da parte di un'ampia clientela
PARIGI–(BUSINESS WIRE)–Abbelight, un leader globale e un pioniere nelle soluzioni complete di microscopia a super risoluzione, oggi ha annunciato il successo di un round di finanziamento di serie B guidato da AVANT BIO, società di capitali di crescit…
Abbelight annonce le succès d’un investissement de série B mené par AVANT BIO afin d’accélérer l’innovation en imagerie et d’étendre son adoption à une clientèle plus large
PARIS–(BUSINESS WIRE)–Abbelight, leader mondial et pionnier dans le domaine des solutions complètes de microscopie à super-résolution, a annoncé aujourd’hui le succès d’un tour de financement de série B mené par AVANT BIO, une société de capital-inve…
Abbelight anuncia el exitoso cierre de una ronda de inversión Serie B liderada por AVANT BIO para acelerar la innovación en imagenología y ampliar su adopción a una base de clientes más amplia
PARÍS–(BUSINESS WIRE)–Abbelight, líder global y empresa pionera en soluciones integrales de microscopía de superresolución, anunció hoy el cierre exitoso de una ronda de financiación Serie B liderada por AVANT BIO, una firma de capital de crecimiento…
Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
AUSTIN, Texas–(BUSINESS WIRE)–Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced positive topline results from its randomized, head-to-head Phase 1b JADE clin…
GenSight Biologics Reports Cash Position as of December 31, 2025, and Provides Business Updates
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for ret…
GenSight Biologics publie sa situation de trésorerie au 31 décembre 2025 et fait un point sur son activité
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (« GenSight Biologics » ou la « Société ») (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), une société biopharmaceutique spécialisée dans le développement et la commercialisation de…
Ashvattha Therapeutics Appoints Life Healthcare Veteran George Montgomery as Executive Chairman to Lead Corporate Development and Strategic Partnerships
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting and reprogramming activa…
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
BARCELONA–(BUSINESS WIRE)–SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced that the first patient has been dosed in the Part B dose-expansion por…
Abbelight Announces Successful Series B Investment led by AVANT BIO to Accelerate Imaging Innovation and Scale Adoption Across a Broader Customer Base
PARIS–(BUSINESS WIRE)–Abbelight, a global leader and a pioneer in super-resolution microscopy end-to-end solutions, today announced a successful Series B financing round led by AVANT BIO, a growth equity firm focused on enabling technologies shaping …
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal–(BUSINESS WIRE)–FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking…
Allotex Advances from European Commercialization to U.S. Clinical Phase
BOSTON–(BUSINESS WIRE)– #eye–Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (…
Allotex Advances from European Commercialization to U.S. Clinical Phase
BOSTON–(BUSINESS WIRE)– #eye–Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (…